Article citationsMore>>

J. Baselga, et al., “Sorafenib in Combination with Capecitabine: An Oral Regimen for Patients with HER2-Negative Locally Advanced or Metastatic Breast Cancer,” Journal of Clinical Oncology, Vol. 30, No. 13, 2012, pp. 1484-1491. doi:10.1200/JCO.2011.36.7771

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top